At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LYT Lytus Technologies Holdings
Not Yet Opened 01-08 16:00:00 EST
0.7496
-0.0704
-8.59%
盘后0.7600
+0.0104+1.39%
19:55 EST
High0.8100Low0.7301Vol797.43K
Open0.8100D1 Closing0.8200Amplitude9.74%
Mkt Cap17.74MTradable Cap16.80MTotal Shares23.66M
T/O603.10KT/O Rate3.56%Tradable Shares22.42M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia
MT Newswires Live  ·  00:57
PureTech Health Gets US FDA Fast Track Designation for LYT-200 to Treat Acute Myeloid Leukemia
BRIEF-PureTech Health Says PRTC's LYT-200 Gets Fast Track Designation In AML
Reuters  ·  01-09 22:34
BRIEF-PureTech Health Says PRTC's LYT-200 Gets Fast Track Designation In AML
PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML
TIPRANKS  ·  01-09 20:15
PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML
PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)
Business Wire  ·  01-09 20:00
PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)
Lytus Technologies Files for Up to $75 Million Mixed Shelf
MT Newswires Live  ·  2024-12-27
Lytus Technologies Files for Up to $75 Million Mixed Shelf
Corrected-Lytus Technologies Holdings Ptv Ltd Files for Mixed Shelf of up to $75 Mln (Adds '$' Symbol, Removes Extraneous Words) - SEC Filing
THOMSON REUTERS  ·  2024-12-27
Corrected-Lytus Technologies Holdings Ptv Ltd Files for Mixed Shelf of up to $75 Mln (Adds '$' Symbol, Removes Extraneous Words) - SEC Filing
BRIEF-Lytus Technologies Holdings Ptv Files For Mixed Shelf Of Up To $75 Mln-SEC Filing
Reuters  ·  2024-12-27
BRIEF-Lytus Technologies Holdings Ptv Files For Mixed Shelf Of Up To $75 Mln-SEC Filing
Lytus Technologies files $75M mixed securities shelf
TIPRANKS  ·  2024-12-27
Lytus Technologies files $75M mixed securities shelf
NASDAQ-Listed LYTUS Appoints Visionary Leader Sai Guna Ranjan Puranam as COO (Lytus Healthcare) and Group CTO (Lytus Technologies) to Revolutionize Healthcare and Technology
PR Newswire  ·  2024-12-16
NASDAQ-Listed LYTUS Appoints Visionary Leader Sai Guna Ranjan Puranam as COO (Lytus Healthcare) and Group CTO (Lytus Technologies) to Revolutionize Healthcare and Technology
PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
Business Wire  ·  2024-12-16
PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
PureTech Health presents data from dose escalation phase of LYT-200 trial
TIPRANKS  ·  2024-12-09
PureTech Health presents data from dose escalation phase of LYT-200 trial
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
Business Wire  ·  2024-12-09
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
Positive Outlook on PureTech Health’s LYT-100 Amid Potential Breakthrough in IPF Treatment
TIPRANKS  ·  2024-11-21
Positive Outlook on PureTech Health’s LYT-100 Amid Potential Breakthrough in IPF Treatment
Potential Upside For Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) Not Without Risk
Simply Wall St.  ·  2024-10-31
Potential Upside For Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) Not Without Risk
PureTech Health presents LYT-100 data at CHEST 2024
TIPRANKS  ·  2024-10-09
PureTech Health presents LYT-100 data at CHEST 2024
PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
Business Wire  ·  2024-10-09
PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
US Markets Flat in Pre-Bell Following Biggest Weekly Gain of 2024
MT Newswires Live  ·  2024-08-19
US Markets Flat in Pre-Bell Following Biggest Weekly Gain of 2024
US Markets Flat in Pre-Bell Following Biggest Weekly Gain of 2024
MT Newswires Live  ·  2024-08-19
US Markets Flat in Pre-Bell Following Biggest Weekly Gain of 2024
Top Premarket Gainers
MT Newswires Live  ·  2024-08-06
Top Premarket Gainers

Introduction

Company Name.
Lytus Technologies Holdings
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Lytus Technologies Holdings PTV. Ltd. operates as a platform services company in India. It operates in two segments, Cable Services and Telemedicine Services. The company engages in the distribution of linear content streaming/telecasting services; and development of telemedicine and fintech products. Lytus Technologies Holdings PTV. Ltd. was incorporated in 2020 and is based in Mumbai, India.
Issue price:
--